Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
NAAG peptidase inhibitors and their potential for diagnosis and therapy
Jia Zhou
, Joseph H. Neale
, Martin G. Pomper
, Alan P. Kozikowski
Research output
:
Contribution to journal
›
Review article
›
peer-review
205
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NAAG peptidase inhibitors and their potential for diagnosis and therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Amyotrophic Lateral Sclerosis
100%
Clinical Trials
100%
Drug Candidates
100%
Enhanced Activity
100%
Glutamatergic Transmission
100%
L-glutamine
100%
N-acetylation
100%
NAAG Peptidase
100%
Neurological Disorders
100%
New Agents
100%
Peptidase Activity
100%
Peptidase Inhibitors
100%
Promising Drug
100%
Prostate Cancer
100%
Schizophrenia
100%
Small Molecule Inhibitors
100%
Traumatic Brain Injury
100%
X-ray Crystal Structure
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acetic Acid Derivative
100%
Amyotrophic Lateral Sclerosis
100%
Aspartic Acid
100%
Clinical Trial
100%
Diseases
100%
Glutamate Carboxypeptidase II Inhibitor
100%
Glutamic Acid
100%
Malignant Neoplasm
100%
Peptidase
100%
Prostate Cancer
100%
Traumatic Brain Injury
100%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Aspartic Acid
100%
Glutamate Carboxypeptidase II
100%
Glutamic Acid
100%
Nervous System Disorder
100%
Neurotrauma
100%
Peptidase
100%
Traumatic Brain Injury
100%